Page 3 of 3 FirstFirst 123
Results 21 to 24 of 24

Thread: ReNetX Bio Launched to Advance Innovative Neuro-Regenerative Technology Developed at

  1. #21
    Senior Member
    Join Date
    Dec 2016
    Location
    Houston, Texas
    Posts
    113
    Never mind I thought he was talking about a different company.

  2. #22
    Senior Member
    Join Date
    Apr 2016
    Location
    Cincinnati, Ohio, USA
    Posts
    1,127
    Quote Originally Posted by nphuskers View Post
    Where did you get that they'll change the focus if successful? Story came out at the end of July that they wanted to start trials on chronic spinal cord injuries in 2018. They have on their website that they want proof of concept done in 2020.

    Here:


    "The trial, which is pending regulatory approval, could begin in as little as 15 months and, if successful, the treatment could begin to restore some sensation and control to patients? limbs within six months to a year. From there, the company would seek to apply the therapy to glaucoma and then stroke damage."
    T3-T7 complete since Sept 2015

  3. #23
    Quote Originally Posted by nphuskers View Post
    I saw this on twitter "Excellent talk from Prof Martin Schwab on phase II clinical trial of anti-Nogo 1 antibodies for #SCI at #isrt2017 @SpinalResearch" (can't figure out how to link tweets) also said they are starting phase II or treatment trials in Dec/Jan

    It was retweeted by spinalresearch
    https://twitter.com/drrdb93/status/903980170163482624
    I'm thinking this isn't connected to ReNetx. There's no mention of Martin Schwab on their website and Schwab did an acute trial of anti-nogo 2006-2011 in Switzerland. Probably a similar situation to chondoitinase, where there are multiple people trying to develop a therapy that aren't connected.

    Also it states on their website they want to use this treatment for acute sci, glaucoma, and stroke. But their first priority is getting it available for chronic sci.

  4. #24
    Senior Member
    Join Date
    Dec 2016
    Location
    Houston, Texas
    Posts
    113
    Update:

    "Thank you so much for signing up for our newsletter. We are excited to share information on the funding commitment between ReNetX Bio and Wings for Life to take the company into clinical trials for Chronic Spinal Cord next year.
    https://globenewswire.com/news-relea...-to-Trial.html


    We will continue to keep you in the loop with additional updates.


    Warmest Regards,
    Erika Smith
    CEO
    ReNetX Bio"


Similar Threads

  1. iPS cell technology in regenerative medicine.
    By wildwilly in forum Stem Cell Research
    Replies: 0
    Last Post: 08-18-2010, 08:42 PM
  2. Innovative equipment technology
    By Eileen in forum Equipment
    Replies: 0
    Last Post: 06-08-2009, 10:50 AM
  3. Replies: 0
    Last Post: 04-23-2009, 10:17 PM
  4. Replies: 11
    Last Post: 03-14-2007, 04:29 PM
  5. Replies: 2
    Last Post: 05-10-2003, 08:36 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •